“…The issues on digitalization of business activity in the pharmaceutical industry were studied by many foreign and Russian scientists (Geissinger, Laurell, Sandström, Eriksson, & Nykvist, 2019;Jirásek, 2017;Kraus, Roig-Tierno, & Bouncken, 2019;Niño-Amézquita, Legotin, & Barbakov, 2017;Andosova, 2019;Ivanova, Poltarykhin, Szromnik, & Anichkina, 2019;Yalmaev, Shalaev, Giyazov, & Tashkulova, 2020;Evstratov, Ezangina, & Novozhenina, 2019, and others). The main questions posed by these authors are the importance of rapid digitalization of the industry, prerequisites for its implementation and possible consequences of such a modernization.…”